
Tempus Expands AI Care Platform to Breast Cancer Treatment
Tempus has expanded its AI-based Care Pathway Intelligence platform to cover breast cancer, following its acquisition of experience in lung, pancreatic, and ovarian cancers. The
Tempus has expanded its AI-based Care Pathway Intelligence platform to cover breast cancer, following its acquisition of experience in lung, pancreatic, and ovarian cancers. The
Fuel up with free Health Tech Insights